These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 31718445

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F, Zegard A, Qiu T, Acquaye E, Ferrante G, Walton J, Marshall H.
    J Am Heart Assoc; 2017 Oct 17; 6(10):. PubMed ID: 29042422
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy.
    Leyva F, Zegard A, Acquaye E, Gubran C, Taylor R, Foley PWX, Umar F, Patel K, Panting J, Marshall H, Qiu T.
    J Am Coll Cardiol; 2017 Sep 05; 70(10):1216-1227. PubMed ID: 28859784
    [Abstract] [Full Text] [Related]

  • 4. Renal function and the long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation.
    Leyva F, Zegard A, Taylor R, Foley PWX, Umar F, Patel K, Panting J, Ferro CJ, Chalil S, Marshall H, Qiu T.
    Pacing Clin Electrophysiol; 2019 Jun 05; 42(6):595-602. PubMed ID: 30873640
    [Abstract] [Full Text] [Related]

  • 5. Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy.
    Leyva F, Zegard A, Umar F, Taylor RJ, Acquaye E, Gubran C, Chalil S, Patel K, Panting J, Marshall H, Qiu T.
    Europace; 2018 Nov 01; 20(11):1804-1812. PubMed ID: 29697764
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y, Zareba W, Goldenberg I, Klein H, McNitt S, Polonsky B, Moss AJ, Kutyifa V, MADIT‐CRT Executive Committee.
    J Am Heart Assoc; 2015 Jun 29; 4(7):. PubMed ID: 26124205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis.
    Shivakumar N, Friedman DJ, Fudim M, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Young J, Tang A, Olivas-Martinez A, Inoue LYT, Sanders GD, Al-Khatib SM.
    J Am Heart Assoc; 2024 Aug 06; 13(15):e031785. PubMed ID: 39082424
    [Abstract] [Full Text] [Related]

  • 12. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.
    Echouffo-Tcheugui JB, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC.
    Eur J Heart Fail; 2019 Sep 06; 21(9):1093-1102. PubMed ID: 31359595
    [Abstract] [Full Text] [Related]

  • 13. Survival after cardiac resynchronization therapy: results from 50 084 implantations.
    Leyva F, Zegard A, Okafor O, de Bono J, McNulty D, Ahmed A, Marshall H, Ray D, Qiu T.
    Europace; 2019 May 01; 21(5):754-762. PubMed ID: 30590500
    [Abstract] [Full Text] [Related]

  • 14. Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation.
    Merkely B, Hatala R, Merkel E, Szigeti M, Veres B, Fábián A, Osztheimer I, Gellér L, Sasov M, Wranicz JK, Földesi C, Duray G, Solomon SD, Kutyifa V, Kovács A, Kosztin A.
    Europace; 2024 Jul 02; 26(7):. PubMed ID: 38979560
    [Abstract] [Full Text] [Related]

  • 15. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.
    Gillis AM, Kerr CR, Philippon F, Newton G, Talajic M, Froeschl M, Froeschl S, Swiggum E, Yetisir E, Wells GA, Tang AS.
    Circulation; 2014 May 20; 129(20):2021-30. PubMed ID: 24610807
    [Abstract] [Full Text] [Related]

  • 16. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R, Selzman KA, Sanders WE, Caños DA, O'Callaghan KM, Carpenter JL, Piña IL, Strauss DG.
    JAMA Intern Med; 2014 Aug 20; 174(8):1340-8. PubMed ID: 25090172
    [Abstract] [Full Text] [Related]

  • 17. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Jensen HK, Nielsen JC.
    Europace; 2016 Mar 20; 18(3):413-9. PubMed ID: 26378089
    [Abstract] [Full Text] [Related]

  • 18. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S, Looi KL, Gajendragadkar PR, Khan FZ, Virdee M, Agarwal S.
    Europace; 2016 Aug 20; 18(8):1187-93. PubMed ID: 26566940
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.